» Articles » PMID: 31583040

Redox Balance Correlates with Nutritional Status Among Patients with End-Stage Renal Disease Treated with Maintenance Hemodialysis

Overview
Publisher Wiley
Date 2019 Oct 5
PMID 31583040
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Over 50% of end-stage renal disease (ESRD) patients die of cardiovascular disease. ESRD patients treated with maintenance hemodialysis are repeatedly exposed to oxidative stress. The aim of the study was to find the relationship between lifestyle factors, nutritional status, calcium-phosphate metabolism, and selected redox parameters such as glutathione peroxidase (GPx), glutathione reductase (GR), superoxide dismutase (SOD), uric acid (UA), and total antioxidant capacity expressed as ferric reducing antioxidant power (FRAP). The study included 97 ESRD hemodialysis patients and 42 controls with no renal disease. Patients were asked to complete a questionnaire which gathered information on their physical activity, hours of sleep, smoking, and frequency of fruit and vegetable intake; the blood samples were then drawn before the midweek dialysis session. The ESRD patients had lower levels of GR, GPx, and SOD activity, a lower level of FRAP, and a higher UA concentration than the control group. The FRAP value decreased with age ( = -0.32, = 0.001); smokers had a significantly lower SOD activity in comparison to nonsmokers ( = 0.03). In the ESRD patients, FRAP and UA correlated with both albumin ( = 0.26, = 0.011; = 0.41, = 0.006, respectively) and prealbumin ( = 0.34, ≤ 0.001; = 0.28, = 0.006, respectively), whereas UA, GR, GPx, and SOD correlated with calcium, UA, GR, and GPx with phosphate level. Based on the findings, there are weak associations between nutritional status and selected redox parameters in hemodialyzed patients. Further studies are needed to establish if diet modifications and adequate nutritional status can positively impact the antioxidant capacity in this group of patients.

Citing Articles

Oxidative Score and Microvesicle Profile Suggest Cardiovascular Risk in Chronic Kidney Disease.

Valera-Arevalo G, Rodriguez-San Pedro M, Caro P, Cabanillas V, Ortiz-Diaz M, Figuer A Antioxidants (Basel). 2025; 14(2).

PMID: 40002365 PMC: 11851666. DOI: 10.3390/antiox14020178.


Oxidative Stress in Patients with Advanced CKD and Renal Replacement Therapy: The Key Role of Peripheral Blood Leukocytes.

Vida C, Oliva C, Yuste C, Ceprian N, Caro P, Valera G Antioxidants (Basel). 2021; 10(7).

PMID: 34356387 PMC: 8301096. DOI: 10.3390/antiox10071155.

References
1.
Montazerifar F, Hashemi M, Karajibani M, Sanadgol H, Dikshit M . Evaluation of lipid peroxidation and erythrocyte glutathione peroxidase and superoxide dismutase in hemodialysis patients. Saudi J Kidney Dis Transpl. 2012; 23(2):274-9. View

2.
Elahi M, Kong Y, Matata B . Oxidative stress as a mediator of cardiovascular disease. Oxid Med Cell Longev. 2010; 2(5):259-69. PMC: 2835914. DOI: 10.4161/oxim.2.5.9441. View

3.
Collins Y, Chouchani E, James A, Menger K, Cocheme H, Murphy M . Mitochondrial redox signalling at a glance. J Cell Sci. 2012; 125(Pt 4):801-6. DOI: 10.1242/jcs.098475. View

4.
deGoma E, Knowles J, Angeli F, Budoff M, Rader D . The evolution and refinement of traditional risk factors for cardiovascular disease. Cardiol Rev. 2011; 20(3):118-29. PMC: 3310946. DOI: 10.1097/CRD.0b013e318239b924. View

5.
Benzie I, Strain J . The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996; 239(1):70-6. DOI: 10.1006/abio.1996.0292. View